Aiming Precision Medicine at Chronic Diseases

Abstract

Get full access to this article

View all access options for this article.

References

CDC. About chronic diseases. https://www.cdc.gov/chronicdisease/about/index.htm

Novo Nordisk Foundation. Precision medicine for cardiometabolic disease: a framework & vision for the future of precision medicine in the diagnosis, preven tion & treatment of complex cardiometabolic disease. https://novonordiskfonden.dk/wp-content/uploads/NNF-white-paper-on-precision-medicine-in-cardiometabolic-disease-%E2%80%93-abridged-version.pdf

International Diabetes Federation. Diabetes now affects one in 10 adults worldwide. https://www.idf.org/news/240:diabetes-now-affects-one-in-10-adults-worldwide.html (2021).

Chung

W.K.

, Erion

, Florez

J.C.

, et al. Precision medicine in diabetes: A consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 43(7):1617–1635 (2020).

Shields

Results of the TriMaster trial. https://www.easd.org/virtualmeeting/home.html#!resources/b-results-of-the-trimaster-trial-b (2021).

, Manne

MS , Treem

W.R.

, et al. Prevalence of inflammatory bowel disease in pediatric and adult populations: Recent estimates from large national databases in the United States, 2007–2016. Inflammatory Bowel Diseases, 26(4):619–625 (2020).

Spencer

, Dubinsky

M.C.

Precision medicine in pediatric inflammatory bowel disease. Pediatric Clinics of North America, 68(6):1171–1190 (2021).

Dubinsky

M.C.

, Irving

P.M.

, Li

, et al. Efficacy and safety of mirokozumab as maintenance therapy in patients with moderate to severely active ulcerative colitis: Results from the Phase 3 LUCENT-2 study. Digestive Disease Week. Presentation Number: 867e. (2022).